N Lawrence Edwards Selected Research

N Lawrence Edwards Research Topics

33	Gout 01/2023 - 11/2006
5	Gouty Arthritis 11/2019 - 07/2008
4	Pain (Aches) 01/2020 - 07/2011
3	Chronic Renal Insufficiency 03/2009 - 11/2006
2	Arthritis (Polyarthritis) 01/2021 - 02/2005
2	Osteoarthritis 01/2021 - 02/2005
2	Inflammation (Inflammations) 09/2016 - 05/2014
2	Rheumatic Diseases (Rheumatism) 10/2015 - 10/2015
2	Kidney Calculi (Kidney Stone) 03/2009 - 07/2008
1	Crystal Arthropathies 01/2021
1	COVID-19 01/2020
1	Hyperuricemia 09/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2010
1	Obesity 08/2010
1	Dizziness (Lightheadedness) 05/2009
1	Headache (Headaches) 05/2009
1	Nausea 05/2009
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2009
1	Stroke (Strokes) 03/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2009

27	Uric Acid (Urate)IBA 01/2023 - 11/2006
8	Pegloticase FDA Link 01/2022 - 08/2011
5	Allopurinol (Remid)FDA LinkGeneric 01/2020 - 05/2009
2	Colchicine FDA LinkGeneric 09/2021 - 01/2020
2	ametantrone (HAQ)IBA 07/2012 - 07/2011
2	Biomarkers (Surrogate Marker)IBA 07/2011 - 06/2011
2	Febuxostat FDA Link 08/2010 - 05/2009
1	AntibodiesIBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2021
1	Calcium PyrophosphateIBA 01/2021
1	Caspase InhibitorsIBA 05/2014
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 05/2014
1	canakinumab FDA Link 05/2014
1	MelanocortinsIBA 05/2014
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 05/2014
1	rilonacept FDA Link 05/2014
1	Indicators and Reagents (Reagents)IBA 07/2011
1	DiureticsIBA 08/2010

16	Therapeutics 01/2023 - 11/2006
3	Ambulatory Care (Outpatient Care) 01/2022 - 01/2020
2	Pain Management 06/2020 - 12/2008
1	Immunomodulation 01/2022
1	Diet Therapy (Therapy, Diet) 03/2016
1	Complementary Therapies (Alternative Medicine) 03/2016
1	Operative Surgical Procedures 02/2005